
Sherwin-Williams (SHW) is drawing investor interest after a mixed stretch in its share performance, with gains over 3 years but negative total returns over the past year, month, and past 3 months.
See our latest analysis for Sherwin-Williams.
The recent 1 day share price return of 3.43% to $313.95 sits against a 30 day share price return decline of 12.94% and a 1 year total shareholder return decline of 7.57%, suggesting near term momentum is fading after stronger multi year gains.
If Sherwin-Williams has you reassessing your watchlist, this is a good moment to broaden your search with a curated set of 20 top founder-led companies
With Sherwin-Williams trading at $313.95 and sitting at a 3.9% implied discount to one intrinsic estimate and a 23.4% discount to the average analyst target, is there real value here or is the market already baking in future growth?
With Sherwin-Williams closing at $313.95 against a narrative fair value of $388.14 based on a 7.62% discount rate, the current price sits well below what this widely followed model considers reasonable.
The company's sustained focus on cost control, broad and deep restructuring (doubling annual savings targets to ~$80 million), and disciplined SG&A management is structurally improving fixed cost leverage and expected to yield improved net margins and earnings power as sales volumes recover. Ongoing construction of a new R&D center and increased R&D investment is expected to accelerate the rollout of premium, environmentally friendly, and specialty coatings that command higher price points, supporting future gross margin expansion and increasing competitive differentiation as sustainability and performance requirements intensify.
Curious what earnings, margin shifts, and future valuation multiple are baked into that fair value gap? The narrative spells out a detailed playbook that ties all three together.
Result: Fair Value of $388.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, weak demand in key end markets and supply chain inefficiencies that pressure margins could quickly narrow the perceived 19.1% valuation gap.
Find out about the key risks to this Sherwin-Williams narrative.
While the narrative fair value suggests upside, the current P/E of 30.1x is higher than both the US Chemicals industry at 26.2x and the peer average at 29x, and also above a fair ratio of 24.7x. That gap points to valuation risk if sentiment or growth expectations cool.
To pressure test that premium against the earnings profile, it helps to look at a simple numerical breakdown. This shows what the current figures imply and how much room there might be for the share price to move toward the fair ratio over time. See what the numbers say about this price — find out in our valuation breakdown.
The mix of concerns and optimism around Sherwin-Williams is clear, and the clock is ticking for you to weigh both sides carefully. Start with 3 key rewards and 1 important warning sign to explore the details.
Do not stop at a single stock when there are countless other opportunities that could fit your goals and risk comfort. Broaden your search while the market is moving.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com